Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

92 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Surveillance of Sentinel Node-Positive Melanoma Patients with Reasons for Exclusion from MSLT-II: Multi-Institutional Propensity Score Matched Analysis.
Broman KK, Hughes TM, Dossett LA, Sun J, Carr MJ, Kirichenko DA, Sharma A, Bartlett EK, Nijhuis AA, Thompson JF, Hieken TJ, Kottschade L, Downs J, Gyorki DE, Stahlie E, van Akkooi A, Ollila DW, Frank J, Song Y, Karakousis G, Moncrieff M, Nobes J, Vetto J, Han D, Farma J, Deneve JL, Fleming MD, Perez M, Baecher K, Lowe M, Bagge RO, Mattsson J, Lee AY, Berman RS, Chai H, Kroon HM, Teras RM, Teras J, Farrow NE, Beasley GM, Hui JY, Been L, Kruijff S, Boulware D, Sarnaik AA, Sondak VK, Zager JS; International High-Risk Melanoma Consortium. Broman KK, et al. Among authors: kottschade l. J Am Coll Surg. 2021 Apr;232(4):424-431. doi: 10.1016/j.jamcollsurg.2020.11.014. Epub 2020 Dec 13. J Am Coll Surg. 2021. PMID: 33316427 Free PMC article.
Defining the Role of the Advanced Practice Provider Within the National Cancer Institute Community Oncology Research Program.
Braun-Inglis CM, Dressler EV, Myers JS, Benson AB 3rd, Flannery M, Good M, Denicoff A, Berenberg JL, DeTroye AT, O'Brien B, Kottschade L, Omatsu DA, Kittel CA, Nightingale CL, Foust M, Lesser GJ. Braun-Inglis CM, et al. Among authors: kottschade l. JCO Oncol Pract. 2024 Feb;20(2):239-246. doi: 10.1200/OP.23.00501. Epub 2024 Jan 4. JCO Oncol Pract. 2024. PMID: 38175992
In-transit melanoma: an individualized approach.
Grotz TE, Mansfield AS, Kottschade LA, Erickson LA, Otley CC, Markovic SN, Jakub JW. Grotz TE, et al. Oncology (Williston Park). 2011 Dec;25(14):1340-8. Oncology (Williston Park). 2011. PMID: 22329185 Free article.
Ipilimumab alone or in combination with nivolumab after progression on anti-PD-1 therapy in advanced melanoma.
Zimmer L, Apuri S, Eroglu Z, Kottschade LA, Forschner A, Gutzmer R, Schlaak M, Heinzerling L, Krackhardt AM, Loquai C, Markovic SN, Joseph RW, Markey K, Utikal JS, Weishaupt C, Goldinger SM, Sondak VK, Zager JS, Schadendorf D, Khushalani NI. Zimmer L, et al. Among authors: kottschade la. Eur J Cancer. 2017 Apr;75:47-55. doi: 10.1016/j.ejca.2017.01.009. Epub 2017 Feb 17. Eur J Cancer. 2017. PMID: 28214657 Clinical Trial.
Neoadjuvant systemic therapy for regionally advanced melanoma.
Jakub JW, Racz JM, Hieken TJ, Gonzalez AB, Kottschade LA, Markovic SN, Yan Y, Block MS. Jakub JW, et al. J Surg Oncol. 2018 May;117(6):1164-1169. doi: 10.1002/jso.24939. Epub 2017 Dec 11. J Surg Oncol. 2018. PMID: 29228467
Sex-Based Differences in Melanoma Survival in a Contemporary Patient Cohort.
Hieken TJ, Glasgow AE, Enninga EAL, Kottschade LA, Dronca RS, Markovic SN, Block MS, Habermann EB. Hieken TJ, et al. Among authors: kottschade la. J Womens Health (Larchmt). 2020 Sep;29(9):1160-1167. doi: 10.1089/jwh.2019.7851. Epub 2020 Feb 27. J Womens Health (Larchmt). 2020. PMID: 32105561 Free PMC article.
92 results